NOT-EY-21-003: Notice of Change: Clarification of Page Limits for RFA-EY-20-001 "NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)"

Notice of Change: Clarification of Page Limits for RFA-EY-20-001 "NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)"

Notice Number:

NOT-EY-21-003

Key Dates

Release Date:

November 23, 2020

Related Announcements

RFA-EY-20-001 - NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)

Issued by

National Eye Institute (NEI)

Purpose

The purpose of this notice is to clarify the page limit requirement for RFA-EY-20-001 "NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)". The page limit for the Research Strategy Section of this FOA is 30 pages.

The following section of the FOA has been changed:

Currently Reads:

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

Revised to read (changes shown in italics):

Section IV. Application and Submission Information

2. Content and Form of Application Submission

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

For this specific FOA, the Research Strategy section is limited to 30 pages.

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Thomas Greenwell
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: Thomas.Greenwell@nih.gov